The sweetener is made mainly of Steviol glycoside plant extracts, having up to 300 times the sweetness of sugar. Because stevia has a negligible effect on blood glucose, it’s attractive as a natural sweetener for people on carbohydrate-controlled diets, such as diabetics.
Shares in Sweetly are to be launched through a crowdfunding investment platform. Often described as ‘democratic finance’, it is a process that allows businesses of all forms and sizes access to funds, while bypassing traditional banking institutions.
The Sweetly shares will offer potential returns that are higher than those generally achieved through mainstream investment products. Investors can invest any amount starting from £50, and such investments can benefit from HM Revenue & Customs approved tax relief.
© FoodBev Media Ltd 2024